Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ocular surface epithelium barrier function refers to the collective physical and biochemical mechanisms by which the epithelial layers of the cornea and conjunctiva protect the eye from environmental insults, pathogens, allergens, and dehydration. This barrier is essential for maintaining corneal transparency, preventing infection, and supporting overall ocular health. Key components include tight junctions, desmosomes, adherens junctions, hemidesmosomes, gap junctions, and the glycocalyx layer. Disruption of this barrier is implicated in several diseases such as dry eye disease and infectious keratitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular Surface Epithelium Barrier Function.